(C) 2009 Elsevier B.V. All rights reserved.”
“Eighteen Girgentana lactating goats, nine homozygous for strong alleles (AA) and nine homozygous for weak alleles (FF) at alpha(s1)-casein (CSN1S1) locus, were used to evaluate the effect of genotype, diet and genotype x diet (G x D) interaction on the composition find protocol of goat milk caseins. Goats were used in a 2 x 2 factorial arrangement of treatments, with two genotypes (AA, FF) and two diets at different energy levels (high-energy diet (D65) and low-energy diet (D100)). The experiment consisted of two simultaneous 2 x 2 Latin squares for the two genotypes, with one square for each level of energy. Capillary electrophoresis was used for the determination of relative
casein (CN) composition. alpha(s1)-CN, kappa-CN and beta-CN yield was significantly higher with 065 than D100 (10.2 vs 7.2; 3.8 vs 2.6; 18.6 vs 13.6 g/d, respectively). Genotype significantly affected (P < 0.05) alpha(s2)-CN and alpha(s1)-CN yield: alpha(s1)-CN was higher in AA than FF goat milk (15.5 vs 2.4 g/d). while alpha(s2)-CN was higher in FF than M goat milk (4.7 vs 2.8 g/d); no genotype effect (P > 0.05) was reported for kappa-CN and beta-CN yield. As concerning individual casein concentration, alpha(s1)-CN was higher for AA than FF goat (12.4 vs 1.5 g/kg milk), whereas alpha(s2)-CN and beta-CN were higher in FF than AA milk (4.3 vs 1.4; 15.6 vs 12.9 g/kg, respectively); also kappa-CN tended to be higher in FF goats. Diet
did not significantly influence
concentration of individual caseins. A significant G x D interaction Ruboxistaurin datasheet was found only for alpha(s1)-CN concentration, which decreased (-10%) when AA goats shifted from D100 to D65. In conclusion, high energy input consistently improved total casein yield beside genotype. The higher casein yield of AA goats mainly depends on ctsiCN biosynthesis; moreover, the lower presence of alpha(s1)-CN in FF goat milk may be partially counterbalanced by the other caseins. (C) 2011 Elsevier B.V. All rights reserved.”
“Background: Sickle cell disease (SCD) is a chronic, incurable hereditary disease. The vaso-occlusive crisis (VOC) is the most frequently occurring acute complication in sickle cell Selleck Belinostat patients and accounts for the majority of SCD-related hospital admissions. Another major complication is the potentially fatal acute chest syndrome (ACS). The prototypic long pentraxin-3 (PTX3), an acute phase protein and a key component of innate immunity, is linked to ischemia-induced inflammation, a condition incriminated in SCD complications. Aim: To investigate the expression of PTX3 in stable SCD and VOC patients and to assess its relation to the development and progression of ACS. Subjects and methods: We conducted this study on 160 patients with confirmed SCD (20 stable SCD and 140 in VOC), and 10 healthy age-and sex-matched controls. Patients were diagnosed as SCD by high-performance liquid chromatography. PTX3 levels were assessed using enzyme-linked immunosorbant assay.